|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income from operations to net cash flows from operating activities: | |||||
| Deconsolidation Charge | |||||
| Non-cash severance charge | |||||
| Depreciation and amortization | |||||
| Charge (credit) for asbestos-related costs, net | |||||
| Deferred income tax (benefit) provision | |||||
| Difference between net periodic pension and other postretirement costs and contributions | |||||
| Stock-based compensation | |||||
| Non-cash (benefit) provisions - net | |||||
| Sale-leaseback accretion | |||||
| Loss on disposal of assets | |||||
| Other – net | |||||
| Changes in assets/liabilities: | |||||
| Receivables | |||||
| Inventories | |||||
| Contract assets | |||||
| Other assets | |||||
| Insurance receivable – asbestos | |||||
| Asbestos liability | |||||
| Accounts payable | |||||
| Accrued payrolls and employee benefits | |||||
| Customer-related liabilities | |||||
| Other liabilities | |||||
| Net cash flows provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from government grants, for purchase of equipment | |||||
| Deconsolidation of UES-UK cash on hand | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchases of long-term marketable securities | |||||
| Proceeds from sale of long-term marketable securities | |||||
| Net cash flows used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Equipment Term Notes | |||||
| Proceeds from revolving credit facility | |||||
| Payments on revolving credit facility | |||||
| Repayment of debt principal | |||||
| Proceeds from sale-leaseback financing arrangements | |||||
| Payments on sale-leaseback financing arrangements | |||||
| Proceeds from equipment financing facility | |||||
| Payments on equipment financing facility | |||||
| Proceeds from related party debt | |||||
| Repayment of related party debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from shareholder exercise of warrants | |||||
| Net cash flows provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income tax payments (net of refunds) | |||||
| Interest payments (net of amounts capitalized) | |||||
| Non-cash investing and financing activities: | |||||
| Purchases of property, plant and equipment in accounts payable | |||||
| Finance lease right-of-use assets exchanged for lease liabilities | |||||
| Operating lease right-of-use assets exchanged for lease liabilities | |||||
Loading...